AVITA MEDICAL INC (RCEL)
US05380C1027 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 29.23M 104.98% | 34.42M 17.76% | 50.143M 45.68% | 70.37M 40.34% | 107.52M 52.79% | 134.52M 25.11% | 138.2M 2.74% | |
| EBITDA YoY % growth | -25.59M 38.93% | -26.56M -3.79% | -41.715M -57.06% | -53.346M -27.88% | -13.811M 74.11% | -7.378M 46.58% | 26.281M 456.21% | |
| EBIT YoY % growth | -26.31M 37.90% | -27.13M -3.12% | -42.347M -56.09% | -55.197M -30.34% | -19.009M 65.56% | -5.107M 73.13% | 25.242M 594.25% | |
| Operating Margin | -90.01% | -78.82% | -84.45% | -78.44% | -17.68% | -3.80% | 18.26% | |
| EPS YoY % growth | -1.17 42.93% | -1.07 8.55% | -1.40 -30.84% | -1.81 -28.96% | -0.80 55.67% | -0.26 67.98% | 0.20 178.74% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.36 -30.05% | -0.47 35.31% | -0.29 51.27% | -0.15 75.87% | -0.05 87.11% | -0.62 -31.53% | -0.20 32.68% | -0.10 30.46% | 0.02 150.00% |
| Revenue Q2Q % growth | 23.63M 66.47% | 22.772M 105.08% | 25.806M 69.83% | 29.325M 50.03% | 32.411M 37.16% | 28.132M 23.54% | 30.228M 17.14% | 33.747M 15.08% | 36.572M 12.84% |
| EBITDA Q2Q % growth | -8.058M 30.32% | -5.202M 69.26% | -2.958M 80.34% | 561K 104.34% | 3.417M 142.41% | N/A | N/A | N/A | -2.448M -171.64% |
| EBIT Q2Q % growth | -8.814M 27.74% | -10.848M 36.65% | -7.575M 50.98% | -4.859M 64.36% | -2.393M 72.84% | -5.814M 46.41% | -5.508M 27.29% | -3.57M 26.52% | -1.326M 44.60% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.62 -82.35% | -0.45 | -0.17 | -39.31% |
| Q2 2024 Q2Q % growth | -0.60 -46.34% | -0.53 | -0.07 | -13.56% |
| Q1 2024 Q2Q % growth | -0.73 -97.30% | -0.48 | -0.25 | -51.24% |
| Q4 2023 Q2Q % growth | -0.28 -27.27% | -0.38 | 0.10 | 26.68% |
| Q3 2023 Q2Q % growth | -0.34 -54.55% | -0.45 | 0.11 | 24.92% |
| Q2 2023 Q2Q % growth | -0.41 -64.00% | -0.33 | -0.08 | -23.91% |
| Q1 2023 Q2Q % growth | -0.37 2.63% | -0.26 | -0.11 | -44.52% |
| Q4 2022 Q2Q % growth | -0.22 -29.41% | -0.30 | 0.08 | 26.20% |
| Q3 2022 Q2Q % growth | -0.22 15.38% | -0.35 | 0.13 | 36.47% |
| Q2 2022 Q2Q % growth | -0.25 3.85% | -0.40 | 0.15 | 37.15% |
| Q1 2022 Q2Q % growth | -0.38 20.83% | -0.39 | 0.01 | 1.96% |
| Q4 2021 Q2Q % growth | -0.17 71.67% | -0.40 | 0.23 | 57.54% |
| Q3 2021 Q2Q % growth | -0.26 63.38% | -0.39 | 0.13 | 32.92% |
| Q2 2021 Q2Q % growth | -0.26 56.67% | -0.29 | 0.03 | 11.34% |
| Q1 2021 Q2Q % growth | -0.48 32.39% | -0.31 | -0.17 | -55.57% |
| Q4 2020 Q2Q % growth | -0.60 | -0.44 | -0.16 | -35.23% |
| Q3 2020 Q2Q % growth | -0.71 | -0.39 | -0.32 | -82.82% |
| Q2 2020 Q2Q % growth | -0.60 | -0.25 | -0.35 | -140.10% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 19.546M 43.25% | 19.814M | -268K | -1.35% |
| Q2 2024 Q2Q % growth | 15.195M 29.29% | 15.028M | 167K | 1.11% |
| Q1 2024 Q2Q % growth | 11.104M 5.25% | 11.268M | -164K | -1.46% |
| Q4 2023 Q2Q % growth | 14.195M 50.05% | 14.79M | -595K | -4.02% |
| Q3 2023 Q2Q % growth | 13.645M 50.11% | 13.635M | 10K | 0.07% |
| Q2 2023 Q2Q % growth | 11.753M 40.92% | 11.547M | 206K | 1.78% |
| Q1 2023 Q2Q % growth | 10.55M 39.92% | 10.538M | 12K | 0.11% |
| Q4 2022 Q2Q % growth | 9.46M 36.31% | 8.849M | 611K | 6.90% |
| Q3 2022 Q2Q % growth | 9.09M 29.49% | 7.173M | 1.917M | 26.73% |
| Q2 2022 Q2Q % growth | 8.34M -19.03% | 7.293M | 1.047M | 14.36% |
| Q1 2022 Q2Q % growth | 7.54M -14.03% | 6.913M | 627K | 9.07% |
| Q4 2021 Q2Q % growth | 6.94M 36.08% | 7.14M | -200K | -2.80% |
| Q3 2021 Q2Q % growth | 7.02M 38.74% | 6.881M | 139.335K | 2.03% |
| Q2 2021 Q2Q % growth | 10.3M 52.01% | 8.043M | 2.257M | 28.06% |
| Q1 2021 Q2Q % growth | 8.77M 76.74% | 6.883M | 1.887M | 27.42% |
| Q4 2020 Q2Q % growth | 5.1M | 5.712M | -612K | -10.71% |
| Q3 2020 Q2Q % growth | 5.06M | 4.998M | 62K | 1.24% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -84.02% | 0% | -4.1% |
| Revenue | 0% | -15.24% | 3.76% | 0.02% |